Previous 10 | Next 10 |
Salt Lake City, UT, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX) , a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today the filing of its operating results on SEC Form 10-Q for the 3 mon...
Salt Lake City, Utah, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX) , a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be presenting at the 71 st annual AACC Scientific ...
Sigma Labs (NASDAQ: SGLB ) +19% to work with airbus to deploy PrintRite3D rapid test and evaluation program More news on: Sigma Labs, Inc., Valeritas Holdings, Inc., RingCentral, Inc., Stocks on the move, Read more ...
Salt Lake City, UT, July 30, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX) , a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today the growing use of the Company’s Vector Smart™ NAM-W...
New York City, New York, July 23, 2019 (GLOBE NEWSWIRE) -- News from Co-Diagnostics, Inc. (Nasdaq: CODX) , a MedTech company with a patented platform for the development of molecular diagnostic tests, recently made CODX one of the hottest tickers of the day following the announcement of ...
Jaguar Health (NASDAQ: JAGX ) -31% . More news on: Jaguar Health, Inc., J. C. Penney Company, Inc., Marker Therapeutics, Inc., Stocks on the move, Read more ...
CODX stock is the biggest gainer on the Nasdaq after Co-Diagnostics Inc (NASDAQ:CODX) announced favorable results from a study to detect cancer mutations using its CoPrimer technology. Key Development Molecular diagnostics company Co-Diagnostics Inc, which has also created a patented pl...
Co-Diagnostics (NASDAQ: CODX ) is up 119% premarket, on announcing favorable results of a study to detect cancer mutations using its CoPrimer technology, with applications in liquid biopsy and companion diagnostic tests. More news on: Co-Diagnostics, Inc., Healthcare stocks n...
Salt Lake City, UT, July 18, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX) , a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today favorable results of a study to detect cancer mutations using its ...
Gainers : Tower International (NYSE: TOWR ) +69% . Camber Energy (NYSEMKT: CEI ) +50% . HOOKIPA Pharma (NASDAQ: HOOK ) +28% . Milacron Holdings (NYSE: MCRN ) +25% . VivoPower International PLC (NASDAQ: VVPR ) +21% . ProQR Therapeutics N.V. (NASDAQ: PRQR ) +21% . Oasmi...
News, Short Squeeze, Breakout and More Instantly...
Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results PR Newswire SALT LAKE CITY , May 9, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX) ("Co-Dx," or the "Company"), a molecular diagnostics company with a unique, patented platform for the de...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast PR Newswire SALT LAKE CITY , April 25, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the developme...